News Conference News EuroPCR 2023 QFR More Consistent Than FFR in Nonculprit Lesions After STEMI Caitlin E. Cox May 24, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2018 STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP? Caitlin E. Cox May 31, 2018
News Conference News EuroPCR 2018 Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents Shelley Wood May 24, 2018
News Conference News EuroPCR 2017 My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not Shelley Wood June 02, 2017
News Conference News EuroPCR 2017 Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis Michael O'Riordan May 19, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows Caitlin E. Cox May 16, 2017
News Conference News EuroPCR 2017 Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate Michael O'Riordan May 15, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Conference News EuroPCR 2013 Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS Yael L. Maxwell May 23, 2013
News Conference News POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients Caitlin E. Cox May 19, 2011
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011